591 related articles for article (PubMed ID: 3397592)
21. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia.
Landgraf H; Grützmacher P; Garcia-Bartels C; Bergmann M; Ehrly AM; Schoeppe W
Eur J Med; 1993; 2(7):393-7. PubMed ID: 8258026
[TBL] [Abstract][Full Text] [Related]
22. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency].
Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F
Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585
[TBL] [Abstract][Full Text] [Related]
23. Guidelines for recombinant human erythropoietin therapy.
Eschbach JW; Adamson JW
Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):2-8. PubMed ID: 2667349
[TBL] [Abstract][Full Text] [Related]
24. The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report.
Adamson W; Egrie JC; Browne JK; Downing MR; Eschbach W
Behring Inst Mitt; 1988 Aug; (83):188-92. PubMed ID: 3071336
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin for anemia.
Med Lett Drugs Ther; 1989 Sep; 31(801):85-6. PubMed ID: 2671624
[No Abstract] [Full Text] [Related]
26. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
[TBL] [Abstract][Full Text] [Related]
28. Daily subcutaneous administration of recombinant human erythropoietin (rhEPO) in peritoneal dialysis patients: a European dose-response study.
Faller B; Slingeneyer A; Waller M; Michel C; Grützmacher P; Müller HP; Barany P; Grabensee B; Issad B; Schmitt H
Clin Nephrol; 1993 Sep; 40(3):168-75. PubMed ID: 8403573
[TBL] [Abstract][Full Text] [Related]
29. Outcome of renal transplantation in patients treated with erythropoietin.
Linde T; Wahlberg J; Wikström B; Danielson BG
Clin Nephrol; 1992 May; 37(5):260-3. PubMed ID: 1606776
[TBL] [Abstract][Full Text] [Related]
30. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
[TBL] [Abstract][Full Text] [Related]
31. Correction of amino acid metabolism by recombinant human erythropoietin therapy in hemodialysis patients.
Riedel E; Hampl H; Scigalla P; Nündel M; Kessel M
Kidney Int Suppl; 1989 Nov; 27():S216-21. PubMed ID: 2636662
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies.
Henry DH; Abels RI
Semin Oncol; 1994 Apr; 21(2 Suppl 3):21-8. PubMed ID: 8202722
[TBL] [Abstract][Full Text] [Related]
33. [The effect of treatment with human recombinant erythropoietin on the functional status of patients on maintenance hemodialysis].
Ermolenko VM; Lashutin SV; Rudakov AG; Fel'd BN; Manakova TE; Kukhtevich AV; Kondakhchan MA; Romanenko NG
Ter Arkh; 1991; 63(6):81-6. PubMed ID: 1948755
[TBL] [Abstract][Full Text] [Related]
34. Changes in the alpha adrenergic system and increase in blood pressure with recombinant human erythropoietin (rHuEpo) therapy for renal anemia.
Müller R; Steffen HM; Brunner R; Saric J; Pollok M; Baldamus CA; Kaufmann W
Clin Invest Med; 1991 Dec; 14(6):614-22. PubMed ID: 1665406
[TBL] [Abstract][Full Text] [Related]
35. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular hemodynamic effects of correction of anemia of chronic renal failure with recombinant-human erythropoietin.
Schwartz AB; Prior JE; Mintz GS; Kim KE; Kahn SB
Transplant Proc; 1991 Apr; 23(2):1827-30. PubMed ID: 2053168
[TBL] [Abstract][Full Text] [Related]
37. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human erythropoietin corrects anemia of blood loss: a study in the dog.
Koumegawa J; Kawahara J; Kubo K; Amano K; Wakimoto N; Takahashi K; Juji T; Takaku F
Int J Cell Cloning; 1990 Mar; 8(2):97-106. PubMed ID: 2313141
[TBL] [Abstract][Full Text] [Related]
39. Who should receive recombinant human erythropoietin?
Van Stone JC
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
[TBL] [Abstract][Full Text] [Related]
40. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
Lim VS
Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
